Dr Reddys Laboratories Ltd Adr (RDY)

12:30 PM

[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.

12:30 PM

Jun 05, 2026

With Lenalidomide Headwinds Behind, Dr. Reddy's Turns to Biosimilars and Consumer Health for Growth - Morningstar

Jun 05, 2026

Jun 05, 2026

Dr. Reddy’s (NYSE: RDY) allots 12,100 ESOP shares, updates capital - Stock Titan

Jun 05, 2026

Jun 05, 2026

Dr. Reddy’s Laboratories issues 12,100 equity shares under stock options scheme - Business Upturn

Jun 05, 2026

Jun 05, 2026

RDY News | DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) - ChartMill

Jun 05, 2026

May 31, 2026

Topicus submits revised $2.00 per share proposal for ReadyTech - Investing.com UK

May 31, 2026

May 31, 2026

Topicus submits revised $2.00 per share proposal for ReadyTech By Investing.com - Investing.com India

May 31, 2026

May 20, 2026

Dr. Reddy's Laboratories Ltd ADR (RDY-N) Stock Price and News - The Globe and Mail

May 20, 2026

May 18, 2026

Earnings call transcript: Dr. Reddy’s Q4 2026 misses earnings expectations - Investing.com UK

May 18, 2026

May 18, 2026

Earnings call transcript: Dr. Reddy’s Q4 2026 misses earnings expectations By Investing.com - Investing.com India

May 18, 2026

May 17, 2026

Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Sahm

May 17, 2026

May 16, 2026

Dr. Reddy's Laboratories Ltd stock (INE089A01023): earnings miss and dual-market focus draw attentio - AD HOC NEWS

May 16, 2026

May 15, 2026

Dr. Reddy's Laboratories stock: Earnings miss shapes outlook - AD HOC NEWS

May 15, 2026

May 13, 2026

Dr. Reddy’s Labs ADR earnings missed by $0.05, revenue fell short of estimates - Investing.com India

May 13, 2026

May 12, 2026

Dr. Reddy's Earnings: Lenalidomide's Slide Digs Into Numbers, but Base Business Remains Solid - Morningstar

May 12, 2026

May 12, 2026

Earnings call transcript: Dr. Reddy’s Q4 2026 revenue misses forecast - Investing.com

May 12, 2026

May 12, 2026

Earnings call transcript: Dr. Reddy’s Q4 2026 revenue misses forecast By Investing.com - Investing.com Australia

May 12, 2026

May 12, 2026

Dr. Reddy's Laboratories Ltd stock (INE089A01023): Board meeting set for Q4 FY26 results - AD HOC NEWS

May 12, 2026

May 11, 2026

Dr. Reddy’s (NYSE: RDY) approves new ESOP and ADR stock option grants - Stock Titan

May 11, 2026

May 11, 2026

Dr. Reddy's Grants Employee Stock Options, Raising Dilution Concerns - Whalesbook

May 11, 2026

May 11, 2026

Dr. Reddy’s Laboratories grants over 1.19 million stock options to employees - Business Upturn

May 11, 2026

May 08, 2026

RDY Stock Price, Quote & Chart | DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) - ChartMill

May 08, 2026

May 06, 2026

Dr. Reddy's Laboratories Ltd. Sponsored ADR Trade Ideas — LS:659157 - TradingView

May 06, 2026

Apr 29, 2026

Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada - ChartMill

Apr 29, 2026

Apr 28, 2026

Earnings BeforeStock ScreenerSnapshot - Finviz

Apr 28, 2026

Apr 23, 2026

Dr. Reddy's on Pace for Largest Percent Increase Since June 2025 — Data Talk - Morningstar

Apr 23, 2026

Apr 19, 2026

Dr. Reddy's Labs (ADR) stock (US2565981035): Why Google Discover changes matter more now - AD HOC NEWS

Apr 19, 2026

Apr 17, 2026

GDR, ADR & IDR Companies Stock Prices | IIFL Capital - India Infoline

Apr 17, 2026

Apr 10, 2026

5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - MSN

Apr 10, 2026

Apr 01, 2026

Dr Reddy’s (NYSE: RDY) Europe head reports 8,450 ADR-backed shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Dr. Reddy’s (NYSE: RDY) North America CEO reports 47,325 ADR shares - Stock Titan

Apr 01, 2026

Mar 30, 2026

ExxonMobil Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Mar 30, 2026

Mar 26, 2026

Dr. Reddy's Laboratories Allots 3,675 Equity Shares Under Employee Stock Option Plan - scanx.trade

Mar 26, 2026

Mar 26, 2026

Employee stock options add 3,675 Dr. Reddy’s (NYSE: RDY) shares - Stock Titan

Mar 26, 2026

Mar 23, 2026

Morgan Stanley Upgraded, Tyson Foods Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Mar 23, 2026

Mar 15, 2026

Dr. Reddy's Laboratories Ltd Stock Faces Analyst Downgrade Despite Strong Valuation—What European - AD HOC NEWS

Mar 15, 2026

Mar 13, 2026

Sapient Quality Select ETF Holdings - Quiver Quantitative

Mar 13, 2026

Mar 12, 2026

Dr. Reddy’s Allots New ESOP Shares, Slightly Increases Equity Capital - TipRanks

Mar 12, 2026

Mar 12, 2026

Dr. Reddy’s (NYSE: RDY) allots 10,275 ESOP shares to employees - Stock Titan

Mar 12, 2026

Mar 12, 2026

Dr. Reddy's Laboratories Announces Special Window for Physical Share Transfer Re-lodgement - scanx.trade

Mar 12, 2026

Mar 12, 2026

Dr. Reddy's Laboratories Allots 10,275 Equity Shares Under Employee Stock Options Scheme - scanx.trade

Mar 12, 2026

Mar 12, 2026

Dr. Reddy’s Laboratories issues 10,275 equity shares under stock options scheme - Business Upturn

Mar 12, 2026

Mar 06, 2026

Dr Reddy's ADR Slumps 10% After Bid To Launch Weight-Loss Drug In Canada Hits Regulatory Hurdle - MSN

Mar 06, 2026

Mar 06, 2026

Mercurity Fintech Holding Inc ADR share price - Mint

Mar 06, 2026

Mar 06, 2026

Mitsubishi UFJ Financial Group Inc ADR share price - Mint

Mar 06, 2026

Mar 05, 2026

3 Generic Drug Stocks to Watch Despite Industry Headwinds - The Globe and Mail

Mar 05, 2026

Feb 27, 2026

DR. Reddy's Laboratories (NYSE:RDY) Fits the Peter Lynch GARP Investment Strategy - ChartMill

Feb 27, 2026

Feb 24, 2026

Dr. Reddy's Laboratories Receives SEC Letter Concluding Investigation Without Enforcement Action - scanx.trade

Feb 24, 2026

Feb 21, 2026

Dr. Reddy’s Stock Pops on US Launch Momentum: Buy the Breakout? - AD HOC NEWS

Feb 21, 2026